Back to Search Start Over

228P The impact of initial tumor response to docetaxel, trastuzumab, and pertuzumab on survival outcomes of patients with HER2+ metastatic breast cancer: An exploratory analysis of the CLEOPATRA trial

Authors :
V. Debien
E. Agostinetto
M. Bruzzone
M. Ceppi
C. Molinelli
D. Martins Branco
F. Jacobs
G. Nader Marta
M. Lambertini
E. de Azambuja
Source :
ESMO Open. 8:101417
Publication Year :
2023
Publisher :
Elsevier BV, 2023.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
20597029
Volume :
8
Database :
OpenAIRE
Journal :
ESMO Open
Accession number :
edsair.doi...........1f289ae494a0f651510caed5d8432cf9
Full Text :
https://doi.org/10.1016/j.esmoop.2023.101417